Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

SAGETRACK

Sign In to gain access to subscriptions and/or personal tools.
Medical Decision Making
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (26)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Ades, A. E.
Right arrow Articles by Higgins, J. P. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ades, A. E.
Right arrow Articles by Higgins, J. P. T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The Interpretation of Random-Effects Meta-Analysis in Decision Models

A. E. Ades, PhD

Medical Research Council, Health Services Research Collaboration, Canynge Hall, Bristol, UK, I.Ades{at}bristol.ac.uk

G. Lu

Medical Research Council, Health Services Research Collaboration, Canynge Hall, Bristol, UK

J. P. T. Higgins, PhD

Medical Research Council Biostatistics Unit, Institute of Public Health, Cambridge, UK

This article shows that the interpretation of the random-effects models used in meta-analysis to summarize heterogeneous treatment effects can have a marked effect on the results from decision models. Sources of variation in meta-analysis include the following: random variation in outcome definition (amounting to a form of measurement error), variation between the patient groups in different trials, variation between protocols, and variation in the way a given protocol is implemented. Each of these alternatives leads to a different model for how the heterogeneity in the effect sizes previously observed might relate to the effect size(s) in a future implementation. Furthermore, these alternative models require different computations and, when the net benefits are nonlinear in the efficacy parameters, result in different expected net benefits. The authors’ analysis suggests that the mean treatment effect from a random-effects meta-analysis will only seldom be an appropriate representation of the efficacy expected in a future implementation. Instead, modelers should consider either the predictive distribution of a future treatment effect, or they should assume that the future implementation will result in a distribution of treatment effects. A worked example, in a probabilistic, Bayesian posterior framework, is used to illustrate the alternative computations and to show how parameter uncertainty can be combined with variation between individuals and heterogeneity in meta-analysis.

Key Words: variation • uncertainty • random effects • meta-analysis • probabilistic decision analysis • Bayesian

Medical Decision Making, Vol. 25, No. 6, 646-654 (2005)
DOI: 10.1177/0272989X05282643


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
BiostatisticsHome page
G. Lu and A. Ades
Modeling between-trial variance structure in mixed treatment comparisons
Biostat., October 1, 2009; 10(4): 792 - 805.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
G. Livesey and R. Taylor
Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies
Am. J. Clinical Nutrition, November 1, 2008; 88(5): 1419 - 1437.
[Abstract] [Full Text] [PDF]


Home page
J Health Serv Res PolicyHome page
A E Ades, N. J Welton, D. Caldwell, M. Price, A. Goubar, and G. Lu
Multiparameter evidence synthesis in epidemiology and medical decision-making
J Health Serv Res Policy, October 1, 2008; 13(suppl_3): 12 - 22.
[Abstract] [Full Text] [PDF]


Home page
Med Decis MakingHome page
A. J. Sutton, N. J. Cooper, S. Goodacre, and M. Stevenson
Integration of Meta-analysis and Economic Decision Modeling for Evaluating Diagnostic Tests
Med Decis Making, September 1, 2008; 28(5): 650 - 667.
[Abstract] [PDF]


Home page
BMJHome page
J. P A Ioannidis, N. A Patsopoulos, and H. R Rothstein
Reasons or excuses for avoiding meta-analysis in forest plots
BMJ, June 21, 2008; 336(7658): 1413 - 1415.
[Full Text] [PDF]


Home page
Med Decis MakingHome page
M. Helfand and L. Saxton
Medical Decision Making and Electronic Publishing
Med Decis Making, March 1, 2007; 27(2): 98 - 100.
[PDF]


Home page
Med Decis MakingHome page
N.J. Welton, I.R. White, G. Lu, J.P.T. Higgins, J. Hilden, and A.E. Ades
Correction: Interpretation of Random Effects Meta-analysis in Decision Models
Med Decis Making, March 1, 2007; 27(2): 212 - 214.
[PDF]